Prelude Capital Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Prelude Capital Management’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-8,500	Closed	-$160K	–	2440
2019 Q3	$160K	Buy	+8,500	New	+$97.2K	0.01%	814

Prelude Capital Management's ALDR Position: Q4 2019 in Review

Prelude Capital Management sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 2,914 shares — an estimated $55K sold.

Prelude Capital Management first reported a position in ALDR in Q4 2014 and held it in 11 quarters. The position peaked at $993K in Q2 2017. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Prelude Capital Management reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Prelude Capital Management sold 2,914 Alder Biopharmaceuticals shares in Q4 2019, an estimated $55K.
Prelude Capital Management first reported a position in Alder Biopharmaceuticals in Q4 2014 and held it in 11 quarters.
Prelude Capital Management's Alder Biopharmaceuticals position peaked at $993K in Q2 2017.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Prelude Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.